BackI-Mab Overview

I-Mab Other Current Assets

Latest other current assets for IMAB: $0.

Get informed when a big investor buys or sells

+ Follow
Other Current Assets
$0.00
↓ 100.00% YoYΔ $-22.99M vs prior year quarter

Peer average / median

Loading

I-Mab Other Current Assets History

Loading

I-Mab vs. peers: Other Current Assets Comparison

Loading

I-Mab Other Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

I-Mab (IMAB) FAQ

As of the most recent data (June 2025), IMAB shows a other current assets of $0. That compares with $23M in the prior-year period — down 100.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, IMAB's other current assets is now $0 (was $23M) — a 100.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether I-Mab is outperforming or lagging.

Tracking IMAB's other current assets over time shows whether I-Mab is scaling, shrinking, or reshaping that part of the business. The current reading is $0 That compares with $23M in the prior-year period — down 100.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current assets page, Stockcircle has I-Mab's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current assets (currently $0) with ownership activity and broader fundamentals.

I-Mab's other current assets is $0; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.